Francais
info@saveyourskin.ca

save your skin foundation

Life After Treatment: Resources for Skin Cancer Survivors

Becoming a skin cancer survivor is not just about defeating a disease; it’s about transitioning from one phase of your life to another. Many melanoma survivors we’ve talked to have said that transitioning into survivorship, despite being the best possible outcome, has its own unique challenges. Suddenly, the care team that had been seeing them regularly is no longer part of their life. And then there’s scanxiety, or the anxiety that many people struggle with when it’s time for their annual maintenance scans.

Kathy Barnard, founder of Save Your Skin Foundation, understands this all too well as she is herself a melanoma stage 4 survivor. That’s why, when she decided to start Save Your Skin Foundation in 2006, she knew she wanted to make sure the foundation supported skin cancer patients throughout the whole continuum of their journey, including survivorship. She also wanted to help survivors and patients connect with each other so they would feel less alone in their journey.

This blog post will give you an overview of the resources we’ve developed to support melanoma and non-melanoma skin cancer survivors. We hope you will find something that can help you on your journey.

Resources for Skin Cancer Survivors

Survivorship Resources

Our Survivorship page lists several resources created specifically for cancer survivors.

skin cancer survivor
skin cancer survivor

Self-Care After Cancer

Our Self-Care After Cancer page offers tons of information for those in remission, including a Q&A that answers common questions asked by new skin cancer survivors.

I’m Living Proof

I’m Living Proof is an interactive map that allows you to find other skin cancer survivors. Simply click on a star to read their story. You can even request to connect with them if you would like to know more or ask a question. We hope these stories of strength and resilience will offer you support and inspiration as you navigate your own path.

skin cancer survivors

Monthly Fireside Chats

Join our Monthly Patient Fireside Chats which have a small standing group of core hosts & new topics every first Thursday of the month. These informal chats are open to patients, survivors, caregivers and family members touched by melanoma, non-melanoma skin cancer, and ocular melanoma. They are discussions about life after a cancer diagnosis, including sharing experiences with treatment options, survivorship, navigating the healthcare system, and any other concern that you might have. It is also a great opportunity to meet other patients and survivors from across Canada.

Webinars

Save your Skin Foundation webinars are a great way to stay up-to-date by listening to patients, survivors, doctors, and pharmaceutical company executives discuss the melanoma, non-melanoma skin cancer, and ocular melanoma landscape. Each webinar features a variety of experts and discusses a different topic.

skin cancer survivor
skin cancer survivor

One-on-one Support

Transitioning into survivorship has its own challenges. Save Your Skin Foundation wishes to bring support to all those in remission. We invite all ocular melanoma, melanoma, and non-melanoma skin cancer patients, at any stage, to get in touch.

As you navigate the complex landscape of life after skin cancer treatment, remember that you are not alone. We invite you to connect with us and fellow survivors, and to help us in creating a community where hope and resilience abound as you embrace this new chapter in your journey.

Get Support

Save Your Skin Foundation wishes to bring hope and support to all those touched by melanoma, non-melanoma skin cancers, or ocular melanoma – whether they are newly diagnosed, currently undergoing treatment, in remission or referred to as “NED” (no evidence of disease).

WE INVITE ALL SKIN CANCER PATIENTS, AT ANY STAGE, TO GET IN TOUCH.

We are here to help. Call us at 1-800-460-5832 or email info@saveyourskin.ca

Read more

Understanding Melanoma Treatment Side Effects

Facing a melanoma diagnosis can be a daunting experience. Thankfully, there are various treatment options available to combat this disease. These treatments offer the potential for recovery and a return to a fulfilling life. It’s important to be aware that, like any medical treatment, melanoma treatments can come with side effects. In this blog post, we’ll explore the side effects associated with the most common treatment types, providing insights that can empower patients to navigate their melanoma treatment journey with confidence.

Immunotherapy Side Effects

Immunotherapy is a treatment that harnesses the body’s immune system to fight cancer cells. As with any treatment, side effects can vary from person to person. They also vary depending on the type of immunotherapy drug. The Canadian Cancer Society  lists the following symptoms:

The side effects of Interferon alfa-2b or interleukin-2 (cytokines) for melanoma may include:

  • Flu-like symptoms: Patients may experience symptoms such as fever, chills, and body aches, reminiscent of the flu.
  • Fatigue: General tiredness is a common side effect.
  • Loss of appetite: Anorexia, or loss of appetite, may occur.
  • Digestive issues: Side effects like diarrhea and nausea/vomiting can affect some patients.
  • Skin problems: A rash may develop as a side effect.
  • Low blood cell counts: Some patients may experience a decrease in blood cell counts.
  • Depression: High-dose interferon alfa-2b may lead to depression.
  • Swelling: Interleukin-2 can lead to swelling due to fluid retention.

The side effects for ipilimumab, nivolumab or pembrolizumab (immune checkpoint inhibitors) may include:

  • Fatigue: Patients may experience increased tiredness.
  • Diarrhea: Digestive issues, including diarrhea, can occur.
  • Skin problems: Some individuals may develop a rash.
  • Headaches: Headaches may be a side effect.
  • Liver problems: Yellowing of the skin and eyes may indicate liver problems.
  • Thyroid problems: Changes in weight, body temperature, heart rate, and blood pressure may result from thyroid issues.
  • Lung problems: Cough and difficulty breathing can be side effects.

It’s important to note that side effects can occur at any time during or after immunotherapy. While most side effects are temporary and can be managed, some may persist over the long term. It is crucial for patients to report any side effects to their healthcare team promptly, as they can offer solutions to alleviate these symptoms and ensure a better treatment experience.

melanoma treatment side effects

Targeted Therapy Side Effects

Targeted therapy is a treatment that specifically attacks cancer cells while sparing healthy cells. This approach typically results in fewer and less severe side effects than traditional chemotherapy or radiation therapy. According to the Canadian Cancer Society, common side effects of targeted therapy for melanoma may include:

  • Skin problems: Rashes and dryness can affect some patients.
  • Sun sensitivity: Patients may become more sensitive to sunlight.
  • Muscle bone and joint pain: Some individuals may experience pain in these areas.
  • Fatigue: General tiredness can occur.
  • Digestive issues: Nausea, vomiting and diarrhea may be side effects.
  • Fever: Patients may run a fever.
  • Eye problems: Some individuals may experience issues with their eyes.
  • Abnormal liver function: Liver problems may arise.
  • Swelling: Edema may develop.

Just like with immunotherapy, side effects from targeted therapy can appear at any time during or after treatment. While many side effects resolve on their own or with medical intervention, it’s crucial for patients to communicate any concerns with their healthcare team.

Radiation Therapy Side Effects

Radiation therapy is designed to target cancer cells with minimal harm to surrounding healthy tissue, but some damage might still occur, causing side effects during, in the days or weeks after or even years after the treatment. According to the Canadian Cancer Society, the side effects will depend on the size and area being treated, the dose and the treatment schedule, The side effects may include:

  • Skin problems: Redness and irritation of the skin may arise.
  • Fatigue: General tiredness can be a side effect.
  • Hair loss: Hair loss can occur in the treated area.
  • Sore mouth and throat: When radiation is aimed at the head or neck, some patients may experience mouth and throat discomfort.
  • Lymphedema: This swelling condition may occur when radiation targets the underarm or groin area.

Similar to other treatments, side effects from radiation therapy can appear at different times. Most of these side effects are manageable, and it’s important for patients to inform their healthcare team of any issues.

Surgery Side Effects

Surgery is a common treatment for melanoma, but it can also have side effects. According to the Canadian Cancer Society, these side effects may include:

  • Pain: Pain is often managed with pain medicines.
  • Scarring: Surgical procedures can result in scarring.
  • Bruising: Some bruising may occur.
  • Changes to skin color: Skin color changes may develop.
  • Wound infection: Infections at the surgical site can occur.
  • Numbness: Some patients may experience numbness in the treated area.
  • Poor healing: Healing issues can arise.
  • Lymphedema: Lymph node dissection may lead to swelling.

As with other treatment methods, side effects from surgery can happen at various times. While most side effects are temporary and can be addressed, open communication with the healthcare team is essential.

In conclusion, melanoma treatment is a complex journey, and understanding the potential side effects is a critical part of it. While these side effects can be challenging, most are manageable with the support and guidance of a healthcare team. It is essential for patients to communicate any side effects promptly, as addressing them early can significantly improve the overall treatment experience and ultimately contribute to a better quality of life during and after melanoma treatment.

Get Support

Save Your Skin Foundation wishes to bring hope and support to all those touched by melanoma, non-melanoma skin cancers, or ocular melanoma – whether they are newly diagnosed, currently undergoing treatment, in remission or referred to as “NED” (no evidence of disease).

WE INVITE ALL SKIN CANCER PATIENTS, AT ANY STAGE, TO GET IN TOUCH.

We are here to help. Call us at 1-800-460-5832 or email info@saveyourskin.ca

Learn about other types of skin cancer:

Basal Cell Carcinoma

BCC is the most common cancer in the world, with incidence exceeding that of all other cancers combined. BCC can develop anywhere, though it is most commonly found in sun exposed areas.

Squamous Cell Carcinoma

Squamous cell carcinoma (SCC), which begins in the keratinocyte cells, is the second most common skin cancer. While SCC usually develops in areas that have been exposed to the sun, it can also manifest in burn or wound sites.

Merkel Cell Carcinoma

Merkel Cell Carcinoma (MCC) is a rare non-melanoma skin cancer. It can develop in the merkel cells, which are found in the deepest areas of the epidermis and hair follicles.

“Immunotherapy for Melanoma Skin Cancer.” Canadian Cancer Society, 2015, cancer.ca/en/cancer-information/cancer-types/skin-melanoma/treatment/immunotherapy. Accessed 27 Oct. 2023.

“Targeted Therapy for Melanoma Skin Cancer.” Canadian Cancer Society, cancer.ca/en/cancer-information/cancer-types/skin-melanoma/treatment/targeted-therapy. Accessed 27 Oct. 2023.

“Radiation Therapy for Melanoma Skin Cancer.” Canadian Cancer Society, cancer.ca/en/cancer-information/cancer-types/skin-melanoma/treatment/radiation-therapy. Accessed 27 Oct. 2023.

Read more

Paxlovid® Submission Survey Results Data

Save Your Skin Foundation is proud to present the findings of our survey, designed to capture the experiences of individuals with COVID-19 in using Paxlovid® as a treatment. This survey welcomed participants from diverse backgrounds, including those who have battled COVID-19, regardless of whether they used Paxlovid®, as well as individuals keen to share their views on accessible treatments for the virus.

The invaluable insights gathered through this survey played a pivotal role in shaping our submissions to the Canadian Agency for Drugs and Technologies in Health (CADTH) and Institut national d’excellence en santé et en services sociaux (INESSS) for access to Paxlovid®.

Save Your Skin Foundation developed this survey to gather patient experiences regarding the use of Paxlovid® as a treatment for COVID-19. The survey was open to everyone who has either experienced COVID-19, regardless of whether they received Paxlovid®, and others who wanted to contribute their opinion on the importance of accessible treatments for COVID-19. This information was used for Save Your Skin Foundation to prepare submissions for access to Paxlovid® to CADTH and INESSS. This survey was endorsed and distributed by a variety of partner patient groups, to whom we are grateful for their support; a complete list of these organizations is available on the final page of this presentation.

Two versions of the survey were open from September 3-September 20, 2023, one in English and one in French. Data from both of the surveys was combined for the aforementioned CADTH and INESSS submissions. For this presentation, visual representations of the English results will be accompanied by a description of the French data for each question.

Lastly, we would like to express our gratitude to the partner patient groups who endorsed and distributed this survey, and we are thankful for their unwavering support. In these results, we will showcase the visual representations of the English survey results, complemented by detailed descriptions of the corresponding data from the French survey. Your participation and contribution have been instrumental in advancing our mission toward accessible and effective COVID-19 treatments.

Read more

Melanoma Treatments: Understanding Your Options

This page explores the various treatment options for melanoma and discusses the latest advancements in the field. Your healthcare team will discuss the best melanoma treatments for you and work with you to develop a treatment plan.

Surgery

Surgery is the primary treatment for early-stage melanoma. There are several surgical approaches, including:

  • Wide Local Excision: This involves removing the melanoma along with some healthy tissue surrounding it. The extent of the removal depends on the thickness and location of the tumor.
  • Sentinel Lymph Node Biopsy: To determine if cancer has spread to the lymph nodes, a sentinel lymph node biopsy may be performed. If cancer is present, more lymph nodes may need to be removed.

 

Immunotherapy

Immunotherapy is a promising approach that harnesses the body’s immune system to fight cancer. Various types of immunotherapy drugs are employed in melanoma treatment, including cytokines like interferon alfa-2b and interleukin-2, which help immune system cells communicate and help control the immune response. Additionally, immune checkpoint inhibitors like Ipilimumab, Nivolumab, and Pembrolizumab are used to block checkpoint proteins that cancer cells use to evade immune attacks.[1]

Targeted Therapy

Targeted therapy targets molecules within cancer cells, such as proteins, that play a role in promoting cell growth and division. By focusing on these molecules, targeted therapy drugs inhibit the growth and spread of cancer cells while minimizing harm to healthy cells. Approximately half of melanoma skin cancers exhibit mutations in the BRAF gene, which drive uncontrolled cell division. MEK and C-KIT gene mutations are less common. Patients with locoregional or metastatic melanoma are often tested for these mutations, and those testing positive may respond to specific targeted therapy drugs.[2]

Radiation Therapy

Radiation therapy employs high-energy rays or particles to destroy melanoma cancer cells. It is used for different purposes, including destroying cancer cells, reducing the risk of cancer recurrence after surgery, and providing relief from pain or symptoms in metastatic cases. External beam radiation therapy, delivered by a machine, is the primary method for treating melanoma skin cancer.[3]

 

Chemotherapy

Traditional chemotherapy is not as effective in treating melanoma as some of the newer therapies. However, it may still be considered in certain cases, such as advanced melanoma that doesn’t respond to other treatments.

 

Clinical Trials

Participating in clinical trials can provide access to cutting-edge treatments and experimental therapies. Many breakthroughs in melanoma treatment have come from clinical trials.

Get Support

Save Your Skin Foundation wishes to bring hope and support to all those touched by melanoma, non-melanoma skin cancers, or ocular melanoma – whether they are newly diagnosed, currently undergoing treatment, in remission or referred to as “NED” (no evidence of disease).

WE INVITE ALL SKIN CANCER PATIENTS, AT ANY STAGE, TO GET IN TOUCH.

We are here to help. Call us at 1-800-460-5832 or email info@saveyourskin.ca

Learn about other types of skin cancer:

Basal Cell Carcinoma

BCC is the most common cancer in the world, with incidence exceeding that of all other cancers combined. BCC can develop anywhere, though it is most commonly found in sun exposed areas.

Squamous Cell Carcinoma

Squamous cell carcinoma (SCC), which begins in the keratinocyte cells, is the second most common skin cancer. While SCC usually develops in areas that have been exposed to the sun, it can also manifest in burn or wound sites.

Merkel Cell Carcinoma

Merkel Cell Carcinoma (MCC) is a rare non-melanoma skin cancer. It can develop in the merkel cells, which are found in the deepest areas of the epidermis and hair follicles.

[1] “Immunotherapy for Melanoma Skin Cancer.” Canadian Cancer Society, 2015, cancer.ca/en/cancer-information/cancer-types/skin-melanoma/treatment/immunotherapy. Accessed 27 Oct. 2023.

[2] “Targeted Therapy for Melanoma Skin Cancer.” Canadian Cancer Society, cancer.ca/en/cancer-information/cancer-types/skin-melanoma/treatment/targeted-therapy. Accessed 27 Oct. 2023.

[3] “Radiation Therapy for Melanoma Skin Cancer.” Canadian Cancer Society, cancer.ca/en/cancer-information/cancer-types/skin-melanoma/treatment/radiation-therapy. Accessed 27 Oct. 2023.

Read more

Opdualag™ Submission Survey Results Data

In the realm of medical breakthroughs, understanding patient experiences is paramount. In this spirit, the Save Your Skin Foundation embarked on a pioneering initiative, delving into the world of melanoma treatment. The survey, titled “The Patient Experience of Nivolumab + Relatlimab (Opdualag™),” crafted meticulously by the foundation, was designed to fathom the depths of Opdualag™ as a treatment for adult cutaneous melanoma in stage III unresectable or stage IV melanoma.

Save Your Skin Foundation developed this survey to gather patient experiences regarding the use of Opdualag™ as a treatment for adult cutaneous melanoma in stage III unresectable or stage IV melanoma. The survey was open to everyone who has received a treatment for melanoma, regardless of stage and experience with Opdualag™; however, data logic has been applied to ensure that only applicable participants answer the questions about Opdualag™. This information was used for Save Your Skin Foundation to prepare submissions for access to Opdualag™ to the Canadian Agency for Drugs and Technologies in Health (CADTH) and Institut national d’excellence en santé et en services sociaux (INESSS).

Two versions of the survey were open from July 3-July 15, 2023, one in English and one in French. Data from both of the surveys was combined for the aforementioned CADTH and INESSS submissions. For this presentation, visual representations of the English results will be accompanied by description of the French data for each question.

Read more

Melanoma on the Leg: Understanding Detection and Prognosis

Melanoma is a serious form of skin cancer that can occur anywhere on the body. While it often develops in areas exposed to the sun, such as the back, legs, arms, and face, it can also appear in less sun-exposed regions. In this blog post, we will explore the key aspects of melanoma on the leg, including its appearance, detection, and prognosis.

Melanoma on the Leg: What You Need to Know

Location Matters for Melanoma Development

Melanomas most commonly develop in areas that have been exposed to the sun, including the legs. It’s essential to recognize that melanomas can also occur in areas with minimal sun exposure, such as the soles of the feet, palms of the hands, and fingernail beds. These hidden melanomas are more frequently found in people with darker skin.

Early Detection is Crucial

Early detection of melanoma can significantly increase the chances of successful treatment. It’s important to regularly examine your skin for anything new, changing, or unusual, not only on sun-exposed areas but also on sun-protected regions. For women, it’s worth noting that melanomas frequently appear on the legs, while men tend to develop them on the trunk.[1] However, melanomas can arise anywhere on the skin, even in areas not directly exposed to the sun.

Melanoma on leg

Appearance of Melanoma on the Leg

Melanoma on the leg may present and behave differently in different people. Characteristics include:

  • Spots, sores, moles, or bumps on the skin that change in shape, size, or color
  • Red or brown colored scaly skin
  • Skin that oozes, bleeds, swells, or may feel painful, itchy, or tender[2]

 

Prognosis and Survival

Location plays a crucial role in the prognosis and survival of melanoma patients. According to the Canadian Cancer Society, having melanoma on the arms or legs generally has a better prognosis than having melanoma on the central part of the body, head, or neck.[3]

Early Detection and Awareness Are Key for Melanomas on the Leg

In conclusion, melanoma can affect any part of the body, including the legs. Early detection and awareness of the appearance of melanomas on the leg are vital for increasing the chances of successful treatment. Regular skin self-exams and understanding the different types and locations of melanoma can make a significant difference in achieving a positive prognosis.

Remember to consult with a healthcare professional if you notice any unusual skin changes or have concerns about melanoma. Your doctor can provide a proper diagnosis, discuss treatment options, and guide you toward the best course of action for your specific situation.‌

Get Support

Save Your Skin Foundation wishes to bring hope and support to all those touched by melanoma, non-melanoma skin cancers, or ocular melanoma – whether they are newly diagnosed, currently undergoing treatment, in remission or referred to as “NED” (no evidence of disease).

WE INVITE ALL SKIN CANCER PATIENTS, AT ANY STAGE, TO GET IN TOUCH.

We are here to help. Call us at 1-800-460-5832 or email info@saveyourskin.ca

Learn about other types of skin cancer:

Basal Cell Carcinoma

BCC is the most common cancer in the world, with incidence exceeding that of all other cancers combined. BCC can develop anywhere, though it is most commonly found in sun exposed areas.

Squamous Cell Carcinoma

Squamous cell carcinoma (SCC), which begins in the keratinocyte cells, is the second most common skin cancer. While SCC usually develops in areas that have been exposed to the sun, it can also manifest in burn or wound sites.

Merkel Cell Carcinoma

Merkel Cell Carcinoma (MCC) is a rare non-melanoma skin cancer. It can develop in the merkel cells, which are found in the deepest areas of the epidermis and hair follicles.

[1] “Melanoma Warning Signs and Images.” The Skin Cancer Foundation, 1 May 2023, www.skincancer.org/skin-cancer-information/melanoma/melanoma-warning-signs-and-images/. Accessed October 24, 2023.

[2] “Skin Cancer on Leg: Appearance and More.” Medical News Today, 17 Apr. 2023, www.medicalnewstoday.com/articles/skin-cancer-on-leg. Accessed 24 Oct. 2023.

[3] Lee, Sid. “Prognosis and Survival for Melanoma Skin Cancer.” Canadian Cancer Society, 2015, cancer.ca/en/cancer-information/cancer-types/skin-melanoma/prognosis-and-survival. Accessed 24 Oct. 2023.

Read more

Is Skin Cancer Dangerous? Understanding the Risks and Prognosis

Skin cancer is a prevalent and potentially life-threatening disease that affects millions of people each year. The question often arises: “Is skin cancer dangerous?” To address this concern, we’ll explore the various types of skin cancer and their potential risks and prognosis.

Melanoma:

Melanoma is one of the most serious forms of skin cancer. The Canadian Cancer Society estimates that it caused 1,200 deaths in Canada in 2022. The outlook for individuals with melanoma can vary significantly. Most melanomas can be cured if detected and treated before they have a chance to spread. Early detection and removal of melanoma are essential for a full recovery.

Non-Melanoma Skin Cancers:

Basal Cell Carcinoma (BCC):

According to the Skin Cancer Foundation, BCC is the most common form of skin cancer, affecting 50,000-60,000 Canadians every year[1]. BCC is generally considered less dangerous than melanoma. However, if not detected and treated early, it can become locally destructive and, in rare instances, metastasize.

Squamous Cell Carcinoma (SCC):

SCC is the second most common form of skin cancer, with an estimated 20,000 cases diagnosed each year in the Canada[2]. Like BCC, SCC can be locally destructive and sometimes metastasize if not detected and treated early.

Merkel Cell Carcinoma (MCC):

MCC is a relatively rare but highly aggressive skin cancer. MCCs are at high risk of recurring and metastasizing, emphasizing the critical importance of early detection and treatment.

Prognostic Factors

The prognosis and survival rates for skin cancer are influenced by several factors, as outlined by the Canadian Cancer Society:

Location: Skin cancer on certain areas, such as around the eyes, nose, lips, ears, scalp, fingers, toes, and genitals, may have a higher risk of recurrence or metastasis.

Size and Depth: Larger tumors and those that have grown deep into the skin are more likely to come back.

Recurrence: Skin cancer that returns after treatment may have a less favorable prognosis.

Type or Subtype: Some subtypes of BCC and SCC tend to grow more quickly and have different outcomes.

Immunosuppression: Weakened immune systems can impact the prognosis.

Stage: The stage at diagnosis is a significant determinant of prognosis.

Outlook for Skin Cancer In general, the outlook for skin cancer is positive. The 5-year survival rate for melanoma is 99% if detected and treated before it spreads to the lymph nodes, according to the American Academy of Dermatology. For BCC and SCC, the outlook is favorable, especially when diagnosed early. However, as skin cancer advances, the prognosis may vary. In conclusion, most skin cancers are curable, especially when detected and treated in their early stages. Early detection, regular check-ups with a dermatologist, and prompt treatment are essential in ensuring a positive outcome. While skin cancer can be a serious diagnosis, advances in medical treatments offer hope and optimism for those affected by this condition. If you have concerns about your specific case, consult with your healthcare provider for personalized guidance on your prognosis and treatment options.

In summary, in answering the question “is skin cancer dangerous?” one must consider various elements such as the type, stage, and other prognostic factors. Melanoma is considered the most dangerous of the common skin cancers, while BCC and SCC can also pose significant risks if not detected and treated promptly. Understanding these risks and working with a healthcare provider to assess prognosis based on individual factors are essential steps in managing and treating skin cancer. Early detection remains the key to improving the prognosis and ensuring a better outcome.

Get Support

Save Your Skin Foundation wishes to bring hope and support to all those touched by melanoma, non-melanoma skin cancers, or ocular melanoma – whether they are newly diagnosed, currently undergoing treatment, in remission or referred to as “NED” (no evidence of disease).

WE INVITE ALL SKIN CANCER PATIENTS, AT ANY STAGE, TO GET IN TOUCH.

We are here to help. Call us at 1-800-460-5832 or email info@saveyourskin.ca

Learn About Immunotherapy

Immunotherapy is a drug treatment that uses the human body’s own immune system to fight cancer.  It may be administered to patients intravenously in the Chemotherapy Unit of the hospital, but it is not the same as chemotherapy.

Learn About Targeted Therapy

Targeted therapy drugs are designed to specifically target cancer cells. For melanoma, these drugs target the activity of a specific or unique feature of melanoma cancer cells.

Learn About Clinical Trials

New treatments are tested in clinical trials before they are approved for general use. There are safeguards in place to ensure clinical trials are as safe as possible and meet medical ethical standards. Participating in a trial can be a way to have access to potentially helpful new therapies you couldn’t get otherwise.

[1] “Basal Cell Carcinoma.” Canadian Skin Cancer Foundation, 26 Mar. 2020, www.canadianskincancerfoundation.com/skin-cancer/basal-cell-carcinoma/. Accessed 20 Oct. 2023.

[2] “Squamous Cell Carcinoma.” Canadian Skin Cancer Foundation, 26 Mar. 2020, www.canadianskincancerfoundation.com/skin-cancer/squamous-cell-carcinoma/. Accessed 20 Oct. 2023.

Read more

Is Skin Cancer Curable?

Skin cancer is a prevalent form of cancer that affects millions of people worldwide. In Canada, about 80,000 people are diagnosed with skin cancer each year.[1] Skin cancer encompasses various types, with the most common being basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. If you or someone you know has been diagnosed with skin cancer, you may be wondering “is skin cancer curable?” The outlook for individuals with skin cancer depends on several factors, including early detection, type, stage, and treatment. Let’s explore what the experts have to say.

 

Early Detection is Key

According to the Cleveland Clinic, nearly all skin cancers can be cured if they’re treated before they have a chance to spread. This emphasizes the crucial role of early detection. The earlier skin cancer is found and removed, the better the chances of a full recovery. It’s essential to schedule regular check-ups with a dermatologist to ensure that any potential issues are identified promptly. If you notice something unusual on your skin, don’t hesitate to contact your doctor.

 

Types of Skin Cancer

As noted by the Cancer Research UK, different types of skin cancer have varying prognoses:

 

Basal cell carcinoma (BCC)

BCC is highly curable, with an extremely low likelihood of spreading to other parts of the body. Most cases can be treated effectively by removing the cancerous tissue along with a small margin of surrounding healthy skin.

 

Squamous Cell Carcinoma (SCC)

SCC is also typically curable, with a high success rate in treatment. In some instances where SCC has spread to lymph nodes or other parts of the body, it may still be curable through appropriate treatment such as surgery, radiation therapy, targeted therapy, or cryotherapy.[2]

 

Melanoma

Early stage melanoma is often curable through surgery.[3] Among the surgical techniques available for melanoma, wide excision is commonly recommended. This procedure involves the complete removal of the cancerous tissue. More advanced melanoma will often require additional forms of treatment, such a s lymph node dissections, immunotherapy and targeted therapy.

Prognostic Factors

The prognosis for non-melanoma skin cancers is generally excellent, but various factors can influence the outcome, as explained by the Canadian Cancer Society. These factors include:

Location: Skin cancer on certain areas, such as around the eyes, nose, lips, ears, scalp, fingers, toes, and genitals, may have a higher risk of recurrence or metastasis.

Size and Depth: Larger tumors and those that have grown deep into the skin are more likely to come back.

Recurrence: Skin cancer that returns after treatment may have a less favorable prognosis.

Type or Subtype: Some subtypes of BCC and SCC tend to grow more quickly and have different outcomes.

Immunosuppression: Weakened immune systems can impact the prognosis.

Stage: The stage at diagnosis is a significant determinant of prognosis.

Outlook for Skin Cancer In general, the outlook for skin cancer is positive. The 5-year survival rate for melanoma is 99% if detected and treated before it spreads to the lymph nodes, according to the American Academy of Dermatology. For BCC and SCC, the outlook is favorable, especially when diagnosed early. However, as skin cancer advances, the prognosis may vary. In conclusion, most skin cancers are curable, especially when detected and treated in their early stages. Early detection, regular check-ups with a dermatologist, and prompt treatment are essential in ensuring a positive outcome. While skin cancer can be a serious diagnosis, advances in medical treatments offer hope and optimism for those affected by this condition. If you have concerns about your specific case, consult with your healthcare provider for personalized guidance on your prognosis and treatment options.

Is Skin Cancer Curable?

In general, the outlook for skin cancer is positive. The 5-year survival rate for melanoma is 99% if detected and treated before it spreads to the lymph nodes, according to the American Academy of Dermatology. For BCC and SCC, the outlook is favorable, especially when diagnosed early. However, as skin cancer advances, the prognosis may vary.

In conclusion, most skin cancers are curable, especially when detected and treated in their early stages. Early detection, regular check-ups with a dermatologist, and prompt treatment are essential in ensuring a positive outcome. While skin cancer can be a serious diagnosis, advances in medical treatments offer hope and optimism for those affected by this condition.

Please remember that the statistics and opinions cited on this page are general, and do not apply to every person’s experience of skin cancer. And if you have concerns about your specific case, consult with your healthcare provider for personalized guidance on your prognosis and treatment options.

Get Support

Save Your Skin Foundation wishes to bring hope and support to all those touched by melanoma, non-melanoma skin cancers, or ocular melanoma – whether they are newly diagnosed, currently undergoing treatment, in remission or referred to as “NED” (no evidence of disease).

WE INVITE ALL SKIN CANCER PATIENTS, AT ANY STAGE, TO GET IN TOUCH.

We are here to help. Call us at 1-800-460-5832 or email info@saveyourskin.ca

Learn More About Immunotherapy

Immunotherapy is a drug treatment that uses the human body’s own immune system to fight cancer.  It may be administered to patients intravenously in the Chemotherapy Unit of the hospital, but it is not the same as chemotherapy.

Learn More About Targeted Therapy

Targeted therapy drugs are designed to specifically target cancer cells. For melanoma, these drugs target the activity of a specific or unique feature of melanoma cancer cells.

Learn More About Clinical Trials

New treatments are tested in clinical trials before they are approved for general use. There are safeguards in place to ensure clinical trials are as safe as possible and meet medical ethical standards. Participating in a trial can be a way to have access to potentially helpful new therapies you couldn’t get otherwise.

[1] “Skin Cancer.” Canadian Skin Cancer Foundation, www.canadianskincancerfoundation.com/skin-cancer/. Accessed 9 Oct. 2023.

[2] “Is Skin Cancer Curable.” Medical News Today, www.medicalnewstoday.com/articles/is-skin-cancer-curable. Accessed 9 Oct. 2023.

[3] “Melanoma Overview.” Skin Cancer Foundation, www.skincancer.org/skin-cancer-information/melanoma/. Accessed 9 Oct. 2023.

Read more

Sty-Lives Can Save Lives: A Conversation with Iveta Voll

Note: this post was authored by Taylor Tomko, Director of Special Projects at SYSF

This month, we are continuing to recruit hairstylists and barbers for our Sty-Lives initiative! Sty-Lives empowers hairdressers to be able to detect suspicious skin lesions on the ears, face and scalp of their clients, facilitating communication between the client and their healthcare provider and leading to earlier detection of potentially dangerous skin cancers. We were recently reminded of the importance of checking the scalp through our community member, Iveta Voll, who unfortunately lost her husband, Steve, in November 2022 to melanoma that initially manifested on his scalp. Recently, I had a call with Iveta, in which we discussed her and Steve’s experience with melanoma and the importance of programs like Sty-Lives.

In November 2019, Steve discovered a scab-like growth on his scalp that he had not previously noticed due to its location. The spot at this point of discovery was already black and large, about the size of a two-dollar coin. After his dermatologist took a biopsy, the spot came back as melanoma that was too deep to be surgically removed. The melanoma had already moved into his lungs, making it stage 4. Steve was immediately referred to a hospital oncologist, and soon began receiving targeted pill therapy to which he had a dramatically positive response. By his next CT scan three months later, all of Steve’s melanoma lesions had vanished. Unfortunately, this treatment does not have a long duration of response, and it only worked for Steve for 14 months.

Once Steve’s melanoma began to return, he began an immunotherapy treatment, followed by another targeted pill therapy, neither of which had positive results. At this point, it was spring 2022. Steve and Iveta were devastated, as the only option left for Steve was a drug trial, hopefully at Princess Margaret Cancer Centre in Toronto. After about a month or so of excruciating waiting, Steve was enrolled in a phase I drug trial, which began just after Thanksgiving 2022. However, this trial meant that Iveta and Steve would have to relocate from Kitchener to Toronto while Steve received the drug. Travelling in four-day cycles between Kitchener and Toronto was challenging for Steve, who had begun to have difficulties catching his breath and an elevated heart rate. A special CT scan showed that he had developed blood clots in his lungs from the cancer. Soon afterwards, it was discovered that Steve’s melanoma had metastasized from his lungs to his liver and was growing very rapidly.

At this point, Steve was told that he unfortunately could not continue in this trial due to the extremely fast-growingmelanoma in his liver. Feeling like they were now truly out of options, Iveta and Steve returned home and updated their local oncologist. It was now early November 2022. At this appointment, Steve was given the devastating prognosis of weeks to months. At the end of that same week, Steve woke up struggling to breathe and his heart rate was extremely high. Iveta called an ambulance, and Steve was admitted to the hospital with a fever, which was likely related to the liver metastasis. Steve stayed in the hospital for five days, spending much time with Iveta, their son, Aaron, and his immediate family. Little did they know that the prognosis of weeks to months would turn out to be just seven short days later; Steve passed away very suddenly on November 8th, 2022 in the hospital surrounded by his loved ones. He and Iveta had been married for 27 years.

Since Steve’s passing, Iveta has started volunteering and is eager to get involved with melanoma-related causes. She, like many of us who have been touched by cancer, wants to ensure that others don’t go through the same painful experience as them. Because Steve’s melanoma appeared on his scalp, she is especially passionate about the Sty-Lives initiative. “Skin cancer is so preventable, and hairdressers can save lives, there’s no doubt about it,” Iveta says, “people visit a hairdresser more often than they visit their family doctor.” Iveta and I talked about the Sty-Lives program at length, including how hairdressers can take on responsibility by having Sty-Lives training, how they can move past any feelings of awkwardness, and how visitors to hair salons can encourage their stylists to get involved. Importantly, as Iveta and I discussed, we are not encouraging hairstylists to try to be doctors or to try to diagnose. Simply alerting their clients of any questionable moles they see on their scalp is sufficient. As Iveta said, “just mention to your client that there’s a suspicious mole(s) on their scalp that they may want to get checked out by a doctor. That’s it. You don’t have to say [whether you] think it’s cancerous or not. Let the client go off and get it explored.”

I raised the question to Iveta about stylists who, for whatever reason, might feel uncomfortable bringing up a mole to their clients. Iveta indicated that the picture is bigger than that, as a hairdresser speaking up could potentially be lifesaving. “I don’t think people are going to get upset if you tell them about a questionable mole or a lesion… I think ninety-nine percent of people would be so thankful,” adding that “it’s better to say more than less.” Hairdressers are, of course, also welcome to ask their clients if they are interested in a mole check at the beginning of the service, to get a sense of whether certain clients will be receptive to it. Iveta asserted that she would certainly be pleased if a hairdresser suggested a mole check during an appointment: “I think if my hairdresser [asked to check my scalp for moles] I would be so impressed. I would give them an extra tip!”

Iveta also brought up the possibility, as citizens who are aware of melanoma, of being proactive with our hairstylists. In addition to mentioning the Sty-Lives initiative to our hairdressers, we can also ask them to keep an eye out for scalp moles during our appointments. “Ask your hairdresser—don’t wait for them,” Iveta suggested, adding that “once that customer asks their hairdresser to check their scalp, guess what? That hairdresser might start doing it for others.” Spreading the word this way, even if hairstylists don’t sign up for the Sty-Lives program, is still extremely beneficial. As Iveta points out, “it’s an issue of awareness, as most people don’t know they can get deadly skin cancer on their scalp.”

Iveta and I finished off our discussion by talking about how to get our own hairstylists involved. If you are reading this and considering mentioning the program to your hairdresser, we encourage you to do so! If they are interested, you can send their contact information to a member of the SYSF team and we will do the rest. We are also currently running the #HairHeroes challenge, where stylists can submit photos or videos of them performing a skin check to be shared on social media. Thank you all for reading and thank you so much to Iveta for her time, thoughts, and support.

Read more

ASCO 2023 Data Report

Earlier this summer, Save Your Skin was fortunate enough to attend the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, in order to hear the latest data from melanoma clinical trials. We are pleased to present the highlights from these exciting studies in our annual ASCO report, which this year includes data from trials relating to melanoma, non-melanoma skin cancers (NMSC), and uveal (ocular) melanoma. Please keep in mind that ASCO is an international association, and therefore studies outlined in this report are not exclusive to Canada.

This report includes:

  • Trial updates related to melanoma, non-melanoma skin cancers (NMSC), and uveal (ocular) melanoma
  • A glossary of abbreviations used in the report
  • A selection of melanoma-related news articles from the summer for supplemental reading

You can read the report here or by clicking on the cover image below. Thank you for reading!

Read more